SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: opalapril who wrote (11324)8/17/1999 12:30:00 PM
From: LJM  Respond to of 17367
 
messages.yahoo.com

This yahoo poster gives Michael Murphey's take on all this. Still a buy at 5 in his opinion.

LJM



To: opalapril who wrote (11324)8/17/1999 12:36:00 PM
From: Thomas J Pittman  Read Replies (1) | Respond to of 17367
 
Question I have is this:

What was significant about the question from the Piper J. analyst regarding 'was it ethical'?

Was what ethical? It had something to do with inclusion of
morbidity?

Did he mean was it ethical for XOMA to change the trial right at the end? Did he mean was it ethical for the FDA to ask that? Did he mean was it ethical to the patients?
That one completely lost me. Who has some guidance for me.

thanks to all

J


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News